Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease
Caused by a polyglutamine expansion in the huntingtin protein, Huntington's disease leads to striatal degeneration via the transcriptional dysregulation of a number of genes, including those involved in mitochondrial biogenesis. Here we show that transglutaminase 2, which is upregulated in HD,...
Saved in:
| Main Author: | Sleiman, Sama F. (author) |
|---|---|
| Other Authors: | Mashishi, Lata (author), Coppola, Giovanni (author), Thompson, Leslie M. (author), Ratan, Rajiv R. (author), Starkov, Anatoly (author), Antonyak, Marc A. (author) |
| Format: | article |
| Published: |
2010
|
| Online Access: | http://hdl.handle.net/10725/6142 http://dx.doi.org/10.1002/emmm.201000084 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://embomolmed.embopress.org/content/2/9/349.short |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation
by: Sleiman, Sama F.
Published: (2012) -
Advances in Huntington’s Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review
by: Sarah Aqel (17787809)
Published: (2025) -
Modulation of caenorhabditis elegans transcription factor activity by HIM-8 and the related zinc-finger ZIM proteins
by: Sleiman, Sama F.
Published: (2007) -
Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition
by: Sleiman, Sama F.
Published: (2014) -
In vitro ischemia suppresses hypoxic induction of hypoxia-inducible factor-1α by inhibition of synthesis and not enhanced degradation
by: Sleiman, Sama F.
Published: (2013)